Navin Fluorine FY26 net profit jumps 130% to ₹663.56 crore

2 min read     Updated on 22 May 2026, 08:27 AM
scanx
Reviewed by
Jubin VScanX News Team
AI Summary

Navin Fluorine International Limited reported a 130% YoY rise in FY26 net profit to ₹663.56 crore, supported by a 41% increase in revenue to ₹3,313.90 crore. Q4 FY26 net profit grew 124% to ₹212.62 crore. The company is executing capex plans worth ₹431.5 crore across HFC, Specialty, and Advanced Materials segments.

powered bylight_fuzz_icon
40964238

*this image is generated using AI for illustrative purposes only.

Navin Fluorine International Limited has announced its financial results for the fiscal year ended March 31, 2026, reporting a 130% year-on-year increase in net profit to ₹663.56 crore. The company achieved this growth on the back of a 41% rise in revenue from operations, which reached ₹3,313.90 crore for FY26. The operating EBITDA for the year stood at ₹1,081.68 crore, marking a 103% YoY increase, with the margin expanding to 32.6%.

Financial Performance Overview

The company’s consolidated financial statements highlight robust growth across key metrics. Profit before tax for FY26 grew 130% to ₹873.17 crore. The operating profit before tax (PBT) saw a similar upward trend, increasing 142% to ₹814.63 crore. For the quarter ended March 31, 2026 (Q4 FY26), revenue from operations was ₹937.71 crore, a 34% increase from the corresponding quarter in the previous year. Net profit for Q4 FY26 rose 124% to ₹212.62 crore.

Segment and Operational Growth

Revenue growth was driven by performance across the company’s three primary business verticals: Hydrofluorocarbon Products (HPP), Specialty Chemicals, and Contract Development and Manufacturing Organization (CDMO). The HPP segment reported a 34% revenue growth for FY26, while Specialty Chemicals and CDMO grew 44% and 59% respectively. The company noted that the pricing environment for HFCs remained constructive throughout the year.

Capital Expenditure and Future Outlook

Navin Fluorine International is advancing several capital expenditure projects to support future growth. The company is investing ₹236.5 crore in additional HFC capacity equivalent to 15,000 MTPA of R32, expected to be commissioned by Q3FY27. Another project involving the de-bottlenecking of MPP capacity at Dahej, with a capex of ₹75 crore, is also targeted for commissioning in Q3FY27. Additionally, the company is setting up initial commercial capacity for advanced materials with a capex of ₹120 crore, targeted for Q1FY27.

Consolidated Financial Results (FY26)

Particulars (₹ Crs.) FY26 FY25 YoY Change
Net Revenue from Operations 3,313.90 2,349.38 41%
Operating EBITDA 1,081.68 533.72 103%
Operating EBITDA Margin 32.6% 22.7% 992 Bps
Profit After Tax 663.56 288.60 130%

Corporate Governance and Investor Meet

The company has scheduled an analyst and institutional investor meet on June 02, 2026, as part of the Axis Capital Rising Stars Conference. The interaction will cover discussions based on publicly available information. Navin Fluorine continues to focus on expanding its footprint in emerging and innovative products while maintaining its commitment to environmental, social, and governance (ESG) standards.

Historical Stock Returns for Navin Fluorine International

1 Day5 Days1 Month6 Months1 Year5 Years
+0.09%+3.37%+11.79%+19.29%+66.94%+122.73%

How might the commissioning of 15,000 MTPA additional HFC capacity in Q3FY27 impact Navin Fluorine's market share amid potential global HFC pricing fluctuations?

What are the long-term revenue and margin targets for the advanced materials segment once the ₹120 crore initial commercial capacity goes live in Q1FY27?

Given the 59% CDMO revenue growth in FY26, which therapeutic areas or global pharma partnerships are likely to drive the next phase of CDMO expansion?

Navin Fluorine International
View Company Insights
View All News
like15
dislike

Navin Fluorine FY26 Net Profit Rises 130% to ₹663.56 Cr

2 min read     Updated on 22 May 2026, 08:10 AM
scanx
Reviewed by
Anirudha BScanX News Team
AI Summary

Navin Fluorine International reported strong financial results for FY26, with net profit rising 130% to ₹663.56 crore and revenue increasing 41% to ₹3,313.90 crore. Operating EBITDA surged 103% to ₹1,081.68 crore, driven by growth across HPP, Specialty Chemicals, and CDMO verticals. The company announced that its officials will meet analysts and investors in Singapore on June 9-10 and in Hong Kong on June 11-12, 2026.

powered bylight_fuzz_icon
40888532

*this image is generated using AI for illustrative purposes only.

Navin Fluorine International has reported its financial results for the fiscal year ended March 31, 2026. The company demonstrated strong performance across key financial metrics, driven by growth in its business verticals including HPP, Specialty Chemicals, and CDMO.

Financial Performance

For the full year FY26, the company’s net revenue from operations increased by 41% to ₹3,313.90 crore, up from ₹2,349.38 crore in FY25. The operating EBITDA surged by 103% to ₹1,081.68 crore, with the operating EBITDA margin expanding significantly to 32.6% from 22.7% in the previous year.

Profit After Tax (PAT) for FY26 rose by 130% to ₹663.56 crore compared to ₹288.60 crore in FY25. The operating Profit Before Tax (PBT) grew by 142% to ₹814.63 crore. On a standalone basis, net revenue from operations stood at ₹2,301.84 crore, with a PAT of ₹487.67 crore.

Quarterly Results

In the fourth quarter of FY26 (Q4FY26), the company reported a net revenue of ₹937.71 crore, a 34% increase year-on-year. The operating EBITDA for the quarter was ₹321.15 crore, an 80% rise, with a margin of 34.2%. PAT for Q4FY26 increased by 124% to ₹212.62 crore.

The following table summarizes the consolidated financial performance for FY26 and Q4FY26:

Particulars (₹ Crs.) Q4 FY26 Q4 FY25 Y-o-Y Change FY26 FY25 Y-o-Y Change
Net Revenue from Operations 937.71 700.94 34% 3,313.90 2,349.38 41%
Operating EBITDA 321.15 178.71 80% 1,081.68 533.72 103%
Operating EBITDA Margin 34.2% 25.5% 875 Bps 32.6% 22.7% 992 Bps
Profit After Tax 212.62 94.98 124% 663.56 288.60 130%

Business Verticals and Capex

Revenue growth was driven by all three business verticals. HPP revenues grew by 34%, Specialty Chemicals by 44%, and CDMO by 59% during FY26. The company is progressing with its ongoing capital expenditure projects, including additional HFC capacity and de-bottlenecking MPP capacity at Dahej.

Investor Meetings

The company announced that its officials will interact with analysts and investors on June 09, 10, 11, and 12, 2026. The meetings on June 09 and 10 will be held physically in Singapore with Jefferies, while the meetings on June 11 and 12 will be held in Hong Kong. The Fund Raising Committee was dissolved with effect from February 09, 2026.

Historical Stock Returns for Navin Fluorine International

1 Day5 Days1 Month6 Months1 Year5 Years
+0.09%+3.37%+11.79%+19.29%+66.94%+122.73%

How might Navin Fluorine's expanded HFC capacity at Dahej position it to capitalize on the global shift away from older refrigerants under the Kigali Amendment?

Given the CDMO segment's 59% revenue growth, which multinational pharma or agrochemical partnerships could drive the next phase of contract manufacturing expansion?

With the Fund Raising Committee dissolved in February 2026, how is Navin Fluorine planning to fund future capex beyond the current Dahej projects — through internal accruals or debt?

Navin Fluorine International
View Company Insights
View All News
like16
dislike

More News on Navin Fluorine International

1 Year Returns:+66.94%